| Bioavailability of curcumin: problems and promises P Anand, AB Kunnumakkara, RA Newman, BB Aggarwal Molecular pharmaceutics 4 (6), 807-818, 2007 | 5987 | 2007 |
| Cancer is a preventable disease that requires major lifestyle changes P Anand, AB Kunnumakara, C Sundaram, KB Harikumar, ST Tharakan, ... Pharmaceutical research 25 (9), 2097-2116, 2008 | 3622 | 2008 |
| Curcumin and cancer: an “old-age” disease with an “age-old” solution P Anand, C Sundaram, S Jhurani, AB Kunnumakkara, BB Aggarwal Cancer letters 267 (1), 133-164, 2008 | 1519 | 2008 |
| Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature P Anand, SG Thomas, AB Kunnumakkara, C Sundaram, KB Harikumar, ... Biochemical pharmacology 76 (11), 1590-1611, 2008 | 1475 | 2008 |
| Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins AB Kunnumakkara, P Anand, BB Aggarwal Cancer letters 269 (2), 199-225, 2008 | 1336 | 2008 |
| RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo P Anand, HB Nair, B Sung, AB Kunnumakkara, VR Yadav, RR Tekmal, ... Biochemical pharmacology 79 (3), 330-338, 2010 | 763 | 2010 |
| Potential of spice-derived phytochemicals for cancer prevention BB Aggarwal, AB Kunnumakkara, KB Harikumar, ST Tharakan, B Sung, ... Planta medica 74 (13), 1560-1569, 2008 | 420 | 2008 |
| Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer KB Harikumar, AB Kunnumakkara, G Sethi, P Diagaradjane, P Anand, ... International journal of cancer 127 (2), 257-268, 2010 | 274 | 2010 |
| Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX‐2, MMP‐9, VEGF and CXCR4 expression in an orthotopic mouse model AB Kunnumakkara, P Diagaradjane, P Anand, HB Kuzhuvelil, ... International journal of cancer 125 (9), 2187-2197, 2009 | 239 | 2009 |
| Mechanical stochastic tug-of-war models cannot explain bidirectional lipid-droplet transport A Kunwar, SK Tripathy, J Xu, MK Mattson, P Anand, R Sigua, M Vershinin, ... Proceedings of the National Academy of Sciences 108 (47), 18960-18965, 2011 | 220 | 2011 |
| Modification of the cysteine residues in IκBα kinase and NF-κB (p65) by xanthohumol leads to suppression of NF-κB–regulated gene products and potentiation of apoptosis in … KB Harikumar, AB Kunnumakkara, KS Ahn, P Anand, S Krishnan, S Guha, ... Blood, The Journal of the American Society of Hematology 113 (9), 2003-2013, 2009 | 196 | 2009 |
| Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model B Sung, AB Kunnumakkara, G Sethi, P Anand, S Guha, BB Aggarwal Molecular cancer therapeutics 8 (4), 959-970, 2009 | 184 | 2009 |
| Comparison of artificial saliva substitutes A Preetha, R Banerjee Trends in Biomaterials and Artificial Organs 18 (2), 178-187, 2005 | 169 | 2005 |
| A novel role for lipid droplets in the organismal antibacterial response P Anand, S Cermelli, Z Li, A Kassan, M Bosch, R Sigua, L Huang, ... elife 1, e00003, 2012 | 137 | 2012 |
| Autoregulatory mechanism for dynactin control of processive and diffusive dynein transport SK Tripathy, SJ Weil, C Chen, P Anand, RB Vallee, SP Gross Nature cell biology 16 (12), 1192-1201, 2014 | 75 | 2014 |
| RETRACTED: Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and … P Anand, B Sung, AB Kunnumakkara, KN Rajasekharan, BB Aggarwal Biochemical pharmacology 82 (12), 1901-1909, 2011 | 64 | 2011 |
| Surface activity, lipid profiles and their implications in cervical cancer. A Preetha, R Banerjee, N Huilgol Journal of cancer research and therapeutics 1 (3), 180-186, 2005 | 46 | 2005 |
| Comparison of paclitaxel penetration in normal and cancerous cervical model monolayer membranes A Preetha, N Huilgol, R Banerjee Colloids and Surfaces B: Biointerfaces 53 (2), 179-186, 2006 | 42 | 2006 |
| Interfacial properties as biophysical markers of cervical cancer A Preetha, N Huilgol, R Banerjee Biomedicine & pharmacotherapy 59 (9), 491-497, 2005 | 42 | 2005 |
| Casein kinase 2 reverses tail-independent inactivation of kinesin-1 J Xu, B Reddy, P Anand, Z Shu, S Cermelli, M Mattson, S Tripathy, ... Biophysical Journal 102 (3), 368a, 2012 | 41 | 2012 |
